| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |